MAI Capital Management 13D and 13G filings for Trevi Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-10 4:16 pm Sale | 2022-05-12 | 13G | Trevi Therapeutics, Inc. TRVI | MAI Capital Management | 1,519,650 2.200% | -21,821 (-1.42%) | Filing |
| 2022-04-08 10:41 am Purchase | 2022-03-30 | 13G | Trevi Therapeutics, Inc. TRVI | MAI Capital Management | 1,541,471 5.000% | 1,541,471 (New Position) | Filing |